Advertisement

Maintenance of Preparedness

  • Timo Wolf
Chapter

Abstract

The medical management of patients with highly hazardous communicable diseases (HHCD) will suddenly become important during public health emergencies of international concern but will receive little attention in between those events. It is very important to use those times to maintain and improve the level of preparedness and adjust it to advances in the field. The infrastructure provided needs to be regularly adjusted but also requires intensive maintenance. Every high-level isolation unit (HLIU) needs to plan individually and very precisely what kind of equipment, materials and medications need to be stockpiled and in what amount, in order to be able to provide adequate care. Providing HLIU treatment is a highly qualified and differentiated task, and training efforts should provide a multidisciplinary HLIU team with an intricate training schedule. The medical and psychological aspects of occupational health and safety need to be addressed as well in order to maintain preparedness.

Keywords

Peacetime intervals Isolation care Standards and procedures Critical infrastructure Infection control Coordination Technical maintenance Stockpiling PPE Medication Staff availability Skills Training Curricula Respiratory health Psychology Team building Patient delivery Intersections Reference laboratories 

References

  1. 1.
    Kortepeter MG, Kwon EH, Hewlett AL, Smith PW, Cieslak TJ. Containment care units for managing patients with highly hazardous infectious diseases: a concept whose time has come. J Inf Dis. 2016;214(S3):S137–41.CrossRefGoogle Scholar
  2. 2.
    Loeb M, McGeer A, Henry B, Ofner M, et al. SARS among critical care nurses, Toronto. Emerg Infect Dis [serial online], 10(2). Available at https://wwwnc.cdc.gov/eid/article/10/2/03-0838_article.CrossRefGoogle Scholar
  3. 3.
    Uyeki T, Mehta AK, Davey RT Jr, Liddell AM, et al. Working Group of the U.S.–European clinical network on clinical management of Ebola virus disease patients in the U.S. and Europe. Clinical management of Ebola virus disease in the United States and Europe. N Engl J Med. 2016;374(7):636–46.CrossRefGoogle Scholar
  4. 4.
    European Center for Disease Prevention. Rapid risk assessment – Lassa fever in Nigeria, Benin, Togo, Germany and USA. http://ecdc.europa.eu/en/publications/Publications/RRA-Lassa-fever-Germany-march-2016.pdf. Accessed 3 May 2017.
  5. 5.
    Bannister B, Puro V, Fusco FM, Heptonstall J, Ippolito G, for the EUNID Working Group. Framework for the design and operation of high-level isolation units: consensus of the European network of infectious diseases. Lancet Infect Dis. 2009;9:45–56.CrossRefGoogle Scholar
  6. 6.
    Zacharowski K, Brodt HR, Wolf T. Medical treatment of an Ebola-infected doctor–ethics over costs? Lancet. 2015;385(9969):685.CrossRefGoogle Scholar
  7. 7.
    Hewlett A, Vasa A, Cieslak TJ, Lowe J, Schwedhelm M. Viral hemorrhagic fever preparedness. In: Bearman M-P, Morgan M, editors. Infection prevention: new perspectives and controversies. New York: Springer. [In Press].Google Scholar
  8. 8.
    Abutaleb Y for Reuters. U.S. Ebola fears fuel new demand for protective gear. October 14, 2014. Online at https://www.yahoo.com/news/u-ebola-fears-fuel-demand-protective-gear-234506969--sector.html. Accessed 13 May 2017.
  9. 9.
    Lai L, Davey R, Beck A, Xu Y, et al. Emergency postexposure vaccination with vesicular stomatitis virus-vectored Ebola vaccine after needlestick. JAMA. 2015;313(12):1249–55.CrossRefGoogle Scholar
  10. 10.
    Baka A, Fusco FM, Puro V, et al. A curriculum for training healthcare workers in the management of highly infectious diseases. Euro Surveill. 2007;12(6):A3.CrossRefGoogle Scholar
  11. 11.
    Murthy S, on behalf of the Ebola Clinical Care authors group. Ebola and provision of critical care. Lancet. 2015;385:1392–3.CrossRefGoogle Scholar
  12. 12.
    Wolf T, Kann G, Becker S, et al. Severe Ebola virus disease with vascular leakage and multiorgan failure: treatment of a patient in intensive care. Lancet. 2014; published online Dec 19. https://doi.org/10.1016/S0140-6736(14)62384-9.CrossRefGoogle Scholar
  13. 13.
    Wolf T, Ross MJ, Davenport A. Minimizing risks associated with renal replacement therapy in patients with Ebola virus disease. Kidney Int. 2015;87:5–7.CrossRefGoogle Scholar
  14. 14.
    Smith PW, Boulter KC, Hewlett AL, et al. Planning and response to Ebola virus disease: an integrated approach. Am J Infect Control. 2015;43(5):441–6. https://doi.org/10.1016/j.ajic.2015.01.019.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Infectious DiseasesUniversity HospitalFrankfurtGermany

Personalised recommendations